The residues of the SARS-CoV-2 main protease (nsp5) involved in binding for remdesivir and Paxlovid (two antivirals recommended by the WHO for COVID-19 treatment in patients at risk of hospital admission) were highly conserved in our sequence dataset, with a percentage of mutated sequences below 0.2%. Here, SPECC1 is linked to COVID-19.